期刊文献+

单链双特异性抗体(BHL-I)介导的细胞毒作用及其可能机制研究 被引量:2

Research on the cytotoxicity and killing mechanism of PBL induced by BHL-I
在线阅读 下载PDF
导出
摘要 目的:观察单链双特异性抗体(BHL-I)介导的PBL对靶细胞SKOV3的杀伤作用,并研究其细胞毒作用的可能机制。方法:MTT法检测在不同效靶比、不同作用时间、不同靶细胞(SKOV3、BEL-7402)、不同BHL-I浓度等条件下,BHL-I介导PBL对靶细胞的杀伤作用;RT-PCR检测杀伤过程中PBL的穿孔素(Perforin)、颗粒酶(GranzymeB)mRNA的表达及细胞培养上清液中TNF-α、IFN-γ含量变化。结果:BHL-I介导的PBL对SKOV3细胞毒作用明显高于对BEL-7402的,并且在效靶比10∶1、作用36小时、BHL-I浓度为25μg/ml时,PBL对靶细胞SKOV3的细胞毒作用最为显著;在IL-2存在下,BHL-I可引起Perforin、GranzymeB mRNA较高表达及细胞培养上清液中TNF-α、IFN-γ含量升高,当作用时间为72小时时,这些细胞因子的表达有所下降。结论:BHL-I能介导PBL对表达有相应靶抗原的SKOV3细胞具有高效杀伤作用,其细胞毒作用可能与效应细胞表达Perforin、GranzymeB、TNF-α、IFN-γ等有关。 Objective:To investigate the PBL single-strand bispecific antibody BHL-I mediated by killing of SKOV3, and to study on possible mechanisms responsible for the phenomenon. Methods: MTF assay was conducted to measure cytotoxicities of PBL against tumors target cells at various concentration of BHL-I. The content of Perforin, GranzymeB mRNA and of hIFN-γ, hTNF-α secreted by PBL in the process of killing target cells, were evaluated by RT-PCR or ELISA. Results:The cytotoxicity of PBL to SKOV3 was more efficient than to BEL-7402, and the PBL had most effective cytotoxicity to SKOV3 when effector/target ratio was at 10: 1. The optional time and concentration for BHL-I co-incubation were 25 μg/ml and 36 h, respectively. Furthermore, the PBL expressed the higher content of Perforin, GranzymeB mRNA and TNF-α, IFN-γ when IL-2 was present together with BHL-I. Whereas they declined when the time continued for 72 h. Condusion:The BHL-I can induce the PBL efficiently to kill the SKOV3 that has relating Ag. The cytotoxicity activity may be associated with the cytotoxic cytokine( Perforin, GranzymeB, TNF-α, IFN-γ) which secreted by activated PBL.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2007年第5期402-406,共5页 Chinese Journal of Immunology
基金 国家重点基础研究发展规划(973)基金资助(No2003CB514113 No2001CB510008)
关键词 单链双特异性抗体 细胞毒作用 杀伤机制 scBsAb Cytotoxicity Killing mechanism
  • 相关文献

参考文献15

  • 1Kipriyanov S M,Le Gall F.Recent advances in the generation of bispecific antibodies for tumor immunotherapy[J].Curr Opin Drug Discov Devel,2004; 7(2):233-242.
  • 2Shahied L S,Tang Y,Alpaugh R K et al.Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format[J].J Biol Chem,2004; 279(52):53907-53914.
  • 3Gruen M,Bommert K,Bargou R C.T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent[J].Cancer Immunol Immunother,2004; 53(7):625-632.
  • 4Honemann D,Kuffer P,Rimpler M M et al.A novel recombinant bispecific single-chain antibody,bscWue-1xCD3,induces T-cell-mediated cytotoxicity towards human multiple myeloma cells[J].Leukemia,2004; 18(3):636-644.
  • 5Jan D J,Carlo H,Marijke D V et al.In vivo retargetign of T cell effector function by recombinant bispecific single chain Fv(Anti-CD3×Anti-Idiotype) induces long-term survival in the murine BCL1 lymphoma model[J].J Immunology,1998; 161(3):1454-1461.
  • 6Van Ravenswaay C H H,Eggermont A M,Nooyen Y A et al.Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies:OV-TL 3/CD3 and OC/TR[J].Gynecol Oncol,1994; 52(2):199-206.
  • 7Fang M,Zhao R,Yang Z H et al.Characterization of an anti-human ovarian carcinoma/anti-human CD3 bispecific single-chain antibody with an albumin-original interlinker[J].Gynecol Oncol,2004; 92(2):135-146.
  • 8Heo D S,Park J G,Hata K et al.Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity[J].Cancer Res,1990; 50(12):3681-3690.
  • 9Sharma V K,Bologa R M,Li B et al.Molecular executors of cell death-differential intrarenal expression of Fas ligand,Fas,granzyme B,and perforin during acute and/or chronic rejection of human renal allografts[J].Transplantation,1996; 62 (12):1860-1866.
  • 10Lipman M L,Stevens A C,Bleackley R C et al.The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection[J].Transplantation,1992; 53 (1):73-79.

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部